» Articles » PMID: 32919034

The Not-so-sweet Side of Sugar: Influence of the Microenvironment on the Processes That Unleash Cancer

Overview
Publisher Elsevier
Date 2020 Sep 12
PMID 32919034
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The role of "aerobic glycolysis" in cancer has been examined often in the past. Results from those studies, most of which were performed on two dimensional conditions (2D, tissue culture plastic), demonstrate that aerobic glycolysis occurs as a consequence of oncogenic events. These oncogenic events often drive malignant cell growth and survival. Although 2D based experiments are useful in elucidating the molecular mechanisms of oncogenesis, they fail to take contributions of the extracellular microenvironment into account. Indeed we, and others, have shown that the cellular microenvironment is essential in regulating processes that induce and/or suppress the malignant phenotype/properties. This regulation between the cell and its microenvironment is both dynamic and reciprocal and involves the integration of cellular signaling networks in the right context. Therefore, given our previous demonstration of the effect of the microenvironment including tissue architecture and media composition on gene expression and the integration of signaling events observed in three-dimension (3D), we hypothesized that glucose uptake and metabolism must also be essential components of the tissue's signal "integration plan" - that is, if uptake and metabolism of glucose were hyperactivated, the canonical oncogenic pathways should also be similarly activated. This hypothesis, if proven true, suggests that direct inhibition of glucose metabolism in cancer cells should either suppress or revert the malignant phenotype in 3D. Here, we review the up-to-date progress that has been made towards understanding the role that glucose metabolism plays in oncogenesis and re-establishing basally polarized acini in malignant human breast cells.

Citing Articles

Fatty acid synthase (FASN) signalome: A molecular guide for precision oncology.

Menendez J, Cuyas E, Encinar J, Steen T, Verdura S, Llop-Hernandez A Mol Oncol. 2023; 18(3):479-516.

PMID: 38158755 PMC: 10920094. DOI: 10.1002/1878-0261.13582.


A medium composition containing normal resting glucose that supports differentiation of primary human airway cells.

Morgan R, Manfredi C, Easley K, Watkins L, Hunt W, Goudy S Sci Rep. 2022; 12(1):1540.

PMID: 35087167 PMC: 8795386. DOI: 10.1038/s41598-022-05446-x.

References
1.
Warburg O . On the origin of cancer cells. Science. 1956; 123(3191):309-14. DOI: 10.1126/science.123.3191.309. View

2.
Kenny P, Lee G, Myers C, Neve R, Semeiks J, Spellman P . The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression. Mol Oncol. 2008; 1(1):84-96. PMC: 2391005. DOI: 10.1016/j.molonc.2007.02.004. View

3.
Gray M, Zhang J, Ellis L, Semenza G, Evans D, Watowich S . HIF-1alpha, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas. Oncogene. 2005; 24(19):3110-20. DOI: 10.1038/sj.onc.1208513. View

4.
Barcellos-Hoff M, Aggeler J, Ram T, Bissell M . Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane. Development. 1989; 105(2):223-35. PMC: 2948482. DOI: 10.1242/dev.105.2.223. View

5.
Bissell M . Mammary gland as a model for studies of gene expression in normal and malignant cells. Prog Clin Biol Res. 1990; 354A:313-6. View